Pignata S, Bookman M, Sehouli J, Miller A, et al. Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer. Gynecol Oncol 2023;177:20-31.
PMID: 37625235